BIOLIFE SOLUTIONS INC — Director's Dealing 2025

Apr 30, 2025

SEC Form 4/A — Form 4/A

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2025-04-07

Reporting Person: Casdin Partners Master Fund, L.P. (10% Owner)
Reporting Person: Casdin Capital, LLC (10% Owner)
Reporting Person: Casdin Partners GP, LLC (10% Owner)
Reporting Person: Casdin Eli (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8707165	Indirect

Footnotes

F1: Pursuant to the acquisition of PanThera CryoSolutions, Inc. ("PanThera") by Biolife Solutions Inc (the "Company"), the Reporting Persons ultimately received cash, instead of the shares reported on the original Form 4. Therefore, the original Form 4 is being amended to delete the transaction that was previously reported therein.

F2: The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.